搜索
ss
ss
关于普米斯
About Us
z349

Lefei Sun (Director)

Managing Director and Head of China Healthcare at General Atlantic. Ph.D from Johns Hopkins University School of Medicine. He has served or current serves as non-executive director of various Healthcare and Life Science companies such as Adagene, OcuMension, CanBridge and Genesis MedTech. He had also led in a USD 200+ million PIPE investment in HutchMed and named as the management advisor. Lefei was once founding partner and a member of the investment committee at Huatai Healthcare Investment Fund, and successfully led strategic investment at Mindray Medical (stock code: 300760) and MIcroPort CardioFlow Medtech (stock code: 02160.HK).
z349
Product description
Parameters

Managing Director and Head of China Healthcare at General Atlantic. Ph.D from Johns Hopkins University School of Medicine. He has served or current serves as non-executive director of various Healthcare and Life Science companies such as Adagene, OcuMension, CanBridge and Genesis MedTech. He had also led in a USD 200+ million PIPE investment in HutchMed and named as the management advisor. Lefei was once founding partner and a member of the investment committee at Huatai Healthcare Investment Fund, and successfully led strategic investment at Mindray Medical (stock code: 300760) and MIcroPort CardioFlow Medtech (stock code: 02160.HK).

Keyword:
董事
投资
医疗
领导
担任
medtech
霍普金斯
成功
约翰
Scan the QR code to read on your phone
We could not find any corresponding parameters, please add them to the properties table
There is currently no content to display
Please add data record on website background.

Copyright: © 2021 Biotheus, Inc.     粤ICP备2021122492号      Powered by www.300.cn